Shandong Polymer Biochemicals Co., Ltd.
Symbol: 002476.SZ
SHZ
4.61
CNYTržní cena dnes
-1078.4464
Poměr P/E
12.5889
Poměr PEG
2.82B
MRK Cap
- 0.00%
Výnos DIV
Shandong Polymer Biochemicals Co., Ltd. (002476-SZ) finanční výkazy
Rozvaha
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1259.11 | 305.6 | 401 | 361.8 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0.31 | 0.3 | 0 | -18.6 | ||||||||||||||||
balance-sheet.row.net-receivables | 1010.97 | 365.1 | 248.1 | 127.9 | ||||||||||||||||
balance-sheet.row.inventory | 426.51 | 84.5 | 82 | 65.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 15.57 | 6.6 | 24.1 | 13.5 | ||||||||||||||||
balance-sheet.row.total-current-assets | 2712.15 | 761.7 | 755.1 | 568.9 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 745.39 | 182.4 | 200.8 | 390 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 441.88 | 10.2 | 10.7 | 11.3 | ||||||||||||||||
balance-sheet.row.long-term-investments | 278.39 | 79.5 | 8.5 | 31.5 | ||||||||||||||||
balance-sheet.row.tax-assets | 20.63 | 5.8 | 6.5 | 7.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 24.19 | 0.4 | 10.8 | 1.2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 1510.49 | 278.2 | 237.3 | 441.1 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.account-payables | 262.9 | 134.6 | 63.1 | 58.5 | ||||||||||||||||
balance-sheet.row.short-term-debt | 60.91 | 11.4 | 1.4 | 43.1 | ||||||||||||||||
balance-sheet.row.tax-payables | 14.29 | 3.2 | 3.9 | 2.1 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0.1 | 77.9 | ||||||||||||||||
Deferred Revenue Non Current | 4.77 | 1.3 | 1.5 | 1.7 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0.34 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 40.68 | 22.8 | 12 | 0.5 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 5.11 | 1.3 | 1.7 | 79.6 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 2.3 | 1.4 | 0.1 | 77.9 | ||||||||||||||||
balance-sheet.row.total-liab | 497.51 | 170.4 | 152.4 | 188 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 2448 | 612 | 612 | 612 | ||||||||||||||||
balance-sheet.row.retained-earnings | 108.28 | 29.1 | -0.5 | -18.5 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 568.62 | 53.5 | 53.5 | 53.5 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 349.96 | 175 | 175 | 175 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 3474.86 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 4222.64 | 1040 | 992.4 | 1010.1 | ||||||||||||||||
balance-sheet.row.minority-interest | 250.28 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 3725.13 | 869.6 | 840 | 822 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 4222.64 | - | - | - | ||||||||||||||||
Total Investments | 278.39 | 79.5 | 8.5 | 12.9 | ||||||||||||||||
balance-sheet.row.total-debt | 60.91 | 11.4 | 1.6 | 43.1 | ||||||||||||||||
balance-sheet.row.net-debt | -1198.2 | -294.2 | -399.4 | -318.8 |
Výkaz peněžních toků
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 9.59 | 34.9 | 38.8 | 40.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0.69 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -0.7 | 0.2 | -3.9 | ||||||||||||||||
cash-flows.row.change-in-working-capital | -164.92 | -153.9 | -101.8 | -33.6 | ||||||||||||||||
cash-flows.row.account-receivables | -161.99 | -162 | -206.5 | -52.2 | ||||||||||||||||
cash-flows.row.inventory | -2.92 | -2.9 | -15.9 | 25.2 | ||||||||||||||||
cash-flows.row.account-payables | 0 | 10.3 | 120.9 | -10.5 | ||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0.7 | -0.2 | 3.9 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 108.17 | 11.2 | 10.2 | 12.3 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 104.27 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.acquisitions-net | -71.17 | 5.5 | 117.5 | 2.4 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -40 | -80 | 0.3 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1.9 | 1.9 | 22.6 | 0 | ||||||||||||||||
cash-flows.row.other-investing-activites | -65.64 | 0.9 | -1.7 | 24.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -117.35 | -86.7 | 119.5 | 8.8 | ||||||||||||||||
cash-flows.row.debt-repayment | -21.82 | -9.9 | -30.3 | -67 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | -0.57 | -0.4 | -5.7 | -10.4 | ||||||||||||||||
cash-flows.row.other-financing-activites | 24.81 | 17.7 | -12 | 7 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 4.15 | 7.3 | -48 | -70.5 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.91 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -8.02 | -157.6 | 36.6 | -29.1 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 1184.3 | 240.6 | 398.2 | 361.5 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 1192.32 | 398.2 | 361.5 | 390.7 | ||||||||||||||||
cash-flows.row.operating-cash-flow | 104.27 | -78.2 | -34.8 | 32.5 | ||||||||||||||||
cash-flows.row.capital-expenditure | -11.7 | -15 | -19.2 | -17.7 | ||||||||||||||||
cash-flows.row.free-cash-flow | 92.56 | -93.2 | -54 | 14.9 |
Řádek výkazu zisku a ztráty
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 479.79 | 592.3 | 657.2 | 447.3 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 384.21 | 462.7 | 557.1 | 363.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 95.58 | 129.6 | 100.1 | 83.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 18.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 11.99 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.operating-expenses | 98.38 | 100.8 | 76.8 | 58.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 482.59 | 563.5 | 633.9 | 421.9 | ||||||||||||||||
income-statement-row.row.interest-income | 6.13 | 6.7 | 5.4 | 5.6 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 26.25 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | 39.57 | 41.2 | 28.9 | 19.7 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 2.98 | 0.3 | -7.6 | -9.8 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.58 | 0.5 | 4.7 | 9.7 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | -4.07 | 36.9 | 38.8 | 40.6 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -4.59 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -0.52 | 30.7 | 25.3 | 26.8 | ||||||||||||||||
income-statement-row.row.income-before-tax | -2.13 | 31.1 | 17.7 | 17.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -0.07 | 1.4 | -0.2 | 3.9 | ||||||||||||||||
income-statement-row.row.net-income | -2.07 | 29.6 | 17.9 | 13.2 |
Často kladené otázky
Co je Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) celková aktiva?
Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) celková aktiva jsou 1039968863.000.
Jaký je roční obrat podniku?
Roční příjmy jsou 212096636.000.
Jaké je ziskové rozpětí podniku?
Zisková marže firmy je 0.199.
Jaký je volný peněžní tok podniku?
Volný peněžní tok je 0.151.
Jaká je čistá zisková marže podniku?
Čistá zisková marže je -0.004.
Jaké jsou celkové tržby podniku?
Celkové příjmy jsou -0.001.
Co je Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) čistý zisk (čistý příjem)?
Čistý zisk (čistý příjem) je 29630378.000.
Jaký je celkový dluh podniku?
Celkový dluh je 11381167.000.
Jaké je číslo provozních nákladů?
Provozní výdaje jsou 100833128.000.
Jaké je číslo peněžních prostředků firmy?
Peněžní prostředky podniku jsou 314019731.000.